603999-19-5 Usage
Uses
Used in Pharmaceutical Synthesis:
3-Furancarboxylic acid, 5-formyl(9CI) is used as a key intermediate in the synthesis of various pharmaceuticals and organic compounds. Its unique structure and reactivity make it a valuable component in the development of new drugs and medicinal agents.
Used in Medicine:
Due to its antioxidant and antimicrobial properties, 3-Furancarboxylic acid, 5-formyl(9CI) has potential applications in the medical field. It can be utilized in the development of treatments for various diseases and conditions, as well as in the preservation and sterilization of medical equipment.
Used in Food Preservation:
The antimicrobial properties of 3-Furancarboxylic acid, 5-formyl(9CI) make it a potential candidate for use in food preservation. It can help extend the shelf life of perishable goods and maintain the quality and safety of food products.
Used in Industrial Production:
3-Furancarboxylic acid, 5-formyl(9CI) may also have potential industrial uses in the production of polymers, resins, and other chemical products. Its versatile reactivity and structure can contribute to the development of new materials and technologies in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 603999-19-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,3,9,9 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 603999-19:
(8*6)+(7*0)+(6*3)+(5*9)+(4*9)+(3*9)+(2*1)+(1*9)=185
185 % 10 = 5
So 603999-19-5 is a valid CAS Registry Number.
InChI:InChI=1/C6H4O4/c7-2-5-1-4(3-10-5)6(8)9/h1-3H,(H,8,9)
603999-19-5Relevant articles and documents
CONDENSED HETEROCYCLIC COMPOUNDS AS CALCITONIN AGONISTS
-
Page/Page column 61-62, (2010/02/07)
The present invention relates to novel fused heterocyclic ring system compounds and methods for their use in the treatment and prevention of diseases or conditions which are related to irregular calcification.
Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
-
, (2008/06/13)
Compounds of the formula STR1 wherein the R 1 groups independently are hydrogen, lower alkyl, or two geminal R 1 groups jointly represent an oxo ( O) or a thio ( S) group; R 2 is hydrogen or lower alkyl, or halogen; M is or --N CR 4 -- or --R 4 C N-- where R 4 is hydrogen or lower alkyl; X is C(R 1) 2 ; Y is phenyl optionally substituted with an R 3 group which is lower alkyl or halogen; A is (CH 2) n where n is 0-5, lower branched chain alkyl, cycloalkyl, alkenyl, alkynyl; B is hydrogen, COOH or a pharmaceutically acceptable salt thereof, COOR 8, CONR 9 R 10, --CH 2 OH, CH 2OR 11, CH 2 OCOR 11, CHO, CH(OR 12) 2, CHOR 13 O, --COR 7, CR 7 (OR 12) 2, or CR 7 OR 13 O, where R 7 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons, R 8 is an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5 to 10 carbons, or R 8 is phenyl or lower alkylphenyl, R 9 and R 10 independently are hydrogen, an alkyl group of 1 to 10 carbons, or a cycloalkyl group of 5-10 carbons, or phenyl or lower alkylphenyl, R 11 is lower alkyl, phenyl or lower alkylphenyl, R 12 is lower alkyl, and R 13 is divalent alkyl radical of 2-5 carbons have retinoid-like biological activity.
